Literature DB >> 11304780

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

N Bijker1, J L Peterse, L Duchateau, J P Julien, I S Fentiman, C Duval, S Di Palma, J Simony-Lafontaine, I de Mascarel, M J van de Vijver.   

Abstract

PURPOSE: In view of the increasing number of patients treated with breast-conserving treatment (BCT) for ductal carcinoma-in-situ (DCIS), risk factors for recurrence and metastasis should be identified. PATIENTS AND METHODS: Clinical and pathologic characteristics from patients with DCIS in the European Organization for Research and Treatment of Cancer trial 10853 (excision with or without radiotherapy) were related to the risk of recurrence. Pathologic features were derived from a central review of 863 of the 1,010 randomized cases (85%). The median follow-up was 5.4 years.
RESULTS: Factors associated with an increased risk of local recurrence in the multivariate analysis were young age (< or = 40 years) (hazard ratio, 2.14; P =.02), symptomatic detection of DCIS (hazard ratio, 1.80; P =.008), growth pattern (solid and cribriform) (hazard ratios, 2.67 and 2.69, respectively; P =.012), involved margins (hazard ratio, 2.07; P =.0008), and treatment by local excision alone (hazard ratio, 1.74; P =.009). The risk of invasive recurrence was not related to the histologic type of DCIS (P =.63), but the risk of distant metastasis was significantly higher in poorly differentiated DCIS compared with well-differentiated DCIS (hazard ratio, 6.57; P =.01).
CONCLUSION: Patients with poorly differentiated DCIS have a high risk of distant metastasis after invasive local recurrence. Margin status is the most important factor in the success of BCT for DCIS; additionally, young age and symptomatic detection of DCIS have negative prognostic value.

Entities:  

Mesh:

Year:  2001        PMID: 11304780     DOI: 10.1200/JCO.2001.19.8.2263

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  91 in total

1.  "Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.

Authors:  Simone De Morgan; Sally Redman; Kate J White; Burcu Cakir; John Boyages
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

Review 2.  Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective.

Authors:  Nina Bijker; Geertjan van Tienhoven
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Progression of Ductal Carcinoma in Situ from the Pathological Perspective.

Authors:  Pedro Oscar R Cunha; Mark Ornstein; J Louise Jones
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

4.  An adequate margin of excision in ductal carcinoma in situ.

Authors:  Malcolm R Kell; Monica Morrow
Journal:  BMJ       Date:  2005-10-08

5.  Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.

Authors:  Aruna Turaka; Gary M Freedman; Tianyu Li; Penny R Anderson; Ramona Swaby; Nicos Nicolaou; Lori Goldstein; Elin R Sigurdson; Richard J Bleicher
Journal:  J Surg Oncol       Date:  2009-07-01       Impact factor: 3.454

6.  Breast cancer guidelines for Uganda (2nd Edition 2008).

Authors:  A Gakwaya; M Galukande; A Luwaga; J Jombwe; J Fualal; E Kiguli-Malwadde; P Baguma; A Kanyike; J B Kigula-Mugamba
Journal:  Afr Health Sci       Date:  2008-06       Impact factor: 0.927

7.  Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile.

Authors:  Satoshi Takahashi; Aye Aye Thike; Valerie Cui Yun Koh; Hironobu Sasano; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2018-07-23       Impact factor: 4.064

8.  Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.

Authors:  I Kong; S A Narod; C Taylor; L Paszat; R Saskin; S Nofech-Moses; D Thiruchelvam; W Hanna; J P Pignol; S Sengupta; L Elavathil; P A Jani; S J Done; S Metcalfe; E Rakovitch
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

9.  Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

Authors:  Laura C Collins; Ninah Achacoso; Larissa Nekhlyudov; Suzanne W Fletcher; Reina Haque; Charles P Quesenberry; Balaram Puligandla; Najeeb S Alshak; Lynn C Goldstein; Allen M Gown; Stuart J Schnitt; Laurel A Habel
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

10.  Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.

Authors:  Patricia A Cronin; Cristina Olcese; Sujata Patil; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2016-05-19       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.